Literature DB >> 20872242

Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association.

Bilal Majed1, Adrien Dozol, Laureen Ribassin-Majed, Kamel Senouci, Bernard Asselain.   

Abstract

Breast cancer (BC) survivors are at increased risk of second cancers. Obesity is commonly recognized as a risk factor of BC in postmenopausal period and a prognosis factor in BC regardless of menopausal status. Our aim was to study whether overweight BC survivors were at increased risk of contralateral BC (CBC). Our population was a large cohort of women followed since a first BC without distant spread and/or synchronous CBC. Body mass index (BMI) was assessed at diagnosis time. Binary codings of BMI were used to oppose overweight and obese patients to the others. Survival analyses were used including Cox models. Assumed hypothesis of proportional hazards was explored using graphical methods, Schoenfeld residuals and time-dependant covariates. In case of non-proportional hazards, survival models were computed over time periods. Over 15,000 patients were included in our study. Incidence of CBC was 8.8 (8.3-9.3)/1000 person-years and increased during follow-up. A significant time-dependent association between overweight and CBC was observed. After 10 years of follow-up, we found a significant increased hazard of CBC among patients with a BMI above 25 kg/m(2): the adjusted hazard ratio was 1.50(1.21-1.86), P = 0.001. After 10 years of follow-up, our study found a poorer prognosis among overweight BC survivors regarding CBC events. While benefits from diet habits and weight control may be expected during the long-term follow-up, they have yet to be established using randomized clinical trials.

Entities:  

Mesh:

Year:  2010        PMID: 20872242     DOI: 10.1007/s10549-010-1153-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

Review 1.  Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.

Authors:  Carlo La Vecchia; Sharon H Giordano; Gabriel N Hortobagyi; Bruce Chabner
Journal:  Oncologist       Date:  2011-05-31

2.  Mammographic breast density is associated with the development of contralateral breast cancer.

Authors:  Akshara Raghavendra; Arup K Sinha; Huong T Le-Petross; Naveen Garg; Limin Hsu; Modesto Patangan; Therese Bartholomew Bevers; Yu Shen; Arun Banu; Debu Tripathy; Isabelle Bedrosian; Carlos H Barcenas
Journal:  Cancer       Date:  2017-01-30       Impact factor: 6.860

3.  Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation.

Authors:  Nadine A Binai; Gert Carra; Johannes Löwer; Roswitha Löwer; Silja Wessler
Journal:  Endocrine       Date:  2013-02-15       Impact factor: 3.633

4.  Body mass index and risk of second primary breast cancer: the WECARE Study.

Authors:  Jennifer D Brooks; Esther M John; Lene Mellemkjær; Anne S Reiner; Kathleen E Malone; Charles F Lynch; Jane C Figueiredo; Robert W Haile; Roy E Shore; Jonine L Bernstein; Leslie Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-09-03       Impact factor: 4.872

Review 5.  Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis.

Authors:  Yuanjie Pang; Yuxia Wei; Christiana Kartsonaki
Journal:  Breast Cancer       Date:  2022-05-17       Impact factor: 3.307

Review 6.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

7.  Occult breast tumor reservoir: biological properties and clinical significance.

Authors:  Richard J Santen; Wei Yue; Daniel F Heitjan
Journal:  Horm Cancer       Date:  2013-04-30       Impact factor: 3.869

8.  Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.

Authors:  Richard J Santen; Wei Yue; Daniel F Heitjan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-14       Impact factor: 4.254

9.  Breast cancer in women using digoxin: tumor characteristics and relapse risk.

Authors:  Robert J Biggar; Elisabeth W Andersen; Niels Kroman; Jan Wohlfahrt; Mads Melbye
Journal:  Breast Cancer Res       Date:  2013-02-19       Impact factor: 6.466

10.  Second malignancies following conventional or combined ²⁵²Cf neutron brachytherapy with external beam radiotherapy for breast cancer.

Authors:  Konstantinas Povilas Valuckas; Vydmantas Atkocius; Irena Kuzmickiene; Eduardas Aleknavicius; Sarune Liukpetryte; Valerijus Ostapenko
Journal:  J Radiat Res       Date:  2013-02-07       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.